384 related articles for article (PubMed ID: 25160945)
1. Ivabradine treatment in a chronic heart failure patient cohort: symptom reduction and improvement in quality of life in clinical practice.
Zugck C; Martinka P; Stöckl G
Adv Ther; 2014 Sep; 31(9):961-74. PubMed ID: 25160945
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and Tolerability of Ivabradine with or Without Concomitant Beta-Blocker Therapy in Patients with Chronic Stable Angina in Routine Clinical Practice.
Perings S; Stöckl G; Kelm M;
Adv Ther; 2016 Sep; 33(9):1550-64. PubMed ID: 27432382
[TBL] [Abstract][Full Text] [Related]
3. Impact of Ivabradine on Health-Related Quality of Life of Patients with Ischaemic Chronic Heart Failure.
Sallam M; Al-Saadi T; Alshekaili L; Al-Zakwani I
Curr Vasc Pharmacol; 2016; 14(5):481-486. PubMed ID: 27145825
[TBL] [Abstract][Full Text] [Related]
4. Ivabradine in combination with beta-blocker reduces symptoms and improves quality of life in elderly patients with stable angina pectoris: age-related results from the ADDITIONS study.
Müller-Werdan U; Stöckl G; Ebelt H; Nuding S; Höpfner F; Werdan K;
Exp Gerontol; 2014 Nov; 59():34-41. PubMed ID: 25193811
[TBL] [Abstract][Full Text] [Related]
5. Long-term treatment with ivabradine over 12months in patients with chronic heart failure in clinical practice: Effect on symptoms, quality of life and hospitalizations.
Zugck C; Störk S; Stöckl G;
Int J Cardiol; 2017 Aug; 240():258-264. PubMed ID: 28408104
[TBL] [Abstract][Full Text] [Related]
6. Addition of ivabradine to β-blocker improves exercise capacity in systolic heart failure patients in a prospective, open-label study.
Bagriy AE; Schukina EV; Samoilova OV; Pricolota OA; Malovichko SI; Pricolota AV; Bagriy EA
Adv Ther; 2015 Feb; 32(2):108-19. PubMed ID: 25700807
[TBL] [Abstract][Full Text] [Related]
7. BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.
Pfisterer M; Buser P; Rickli H; Gutmann M; Erne P; Rickenbacher P; Vuillomenet A; Jeker U; Dubach P; Beer H; Yoon SI; Suter T; Osterhues HH; Schieber MM; Hilti P; Schindler R; Brunner-La Rocca HP;
JAMA; 2009 Jan; 301(4):383-92. PubMed ID: 19176440
[TBL] [Abstract][Full Text] [Related]
8. Quality of life improvement in older patients with heart failure initiated on ivabradine: Results from the UK multi-centre LIVE:LIFE prospective cohort study.
Zachariah D; Stevens D; Sidorowicz G; Spooner C; Rowell N; Taylor J; Kay R; Salek MS; Kalra PR;
Int J Cardiol; 2017 Dec; 249():313-318. PubMed ID: 29121732
[TBL] [Abstract][Full Text] [Related]
9. Real-life indications to ivabradine treatment for heart rate optimization in patients with chronic systolic heart failure.
Tondi L; Fragasso G; Spoladore R; Pinto G; Gemma M; Slavich M; Godino C; Salerno A; Montanaro C; Margonato A
J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):351-356. PubMed ID: 29762337
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacological therapy of heart failure with reduced ejection fraction].
Wieser M; Rhyner D; Martinelli M; Suter T; Schnegg B; Bösch C; Wigger O; Dobner S; Hunziker L
Ther Umsch; 2018 Sep; 75(3):180-186. PubMed ID: 30145973
[TBL] [Abstract][Full Text] [Related]
11. Effects of ivabradine therapy on heart failure biomarkers.
Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
[TBL] [Abstract][Full Text] [Related]
12. [Ivabradine for Treatment of Heart Failure with Preserved Ejection Fraction].
Babushkina GV; Shaikhlislamova GI
Kardiologiia; 2020 Oct; 60(10):33-37. PubMed ID: 33228503
[TBL] [Abstract][Full Text] [Related]
13. Physicians' adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey.
Komajda M; Anker SD; Cowie MR; Filippatos GS; Mengelle B; Ponikowski P; Tavazzi L;
Eur J Heart Fail; 2016 May; 18(5):514-22. PubMed ID: 27095461
[TBL] [Abstract][Full Text] [Related]
14. [Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of Sadko-CHF study)].
Skvortsov AA; Mareev VIu; Nasonova SN; Sychev AV; Arbolishvili GN; Baklanova NA; Masenko VP; Belenkov IuN
Ter Arkh; 2006; 78(8):14-20. PubMed ID: 17078211
[TBL] [Abstract][Full Text] [Related]
15. Ivabradine for the treatment of chronic heart failure.
Henri C; O'Meara E; De Denus S; Elzir L; Tardif JC
Expert Rev Cardiovasc Ther; 2016; 14(5):553-61. PubMed ID: 26967048
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy and safety analysis of ivabradine hydrochloride treatment of Chinese patients with chronic heart failure: subgroup analysis of Chinese patients in the SHIFT study].
Hu DY; Huang DJ; Yuan ZY; Zhao RP; Yan XW; Wang MH;
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Mar; 45(3):190-197. PubMed ID: 28316174
[No Abstract] [Full Text] [Related]
17. Can BNP-guided therapy improve health-related quality of life, and do responders to BNP-guided heart failure treatment have improved health-related quality of life? Results from the UPSTEP study.
Karlström P; Johansson P; Dahlström U; Boman K; Alehagen U
BMC Cardiovasc Disord; 2016 Feb; 16():39. PubMed ID: 26905220
[TBL] [Abstract][Full Text] [Related]
18. A management programme for suspected heart failure in primary care in cooperation with specialists in cardiology.
Mejhert M; Kahan T
Eur J Gen Pract; 2015 Mar; 21(1):26-32. PubMed ID: 25342003
[TBL] [Abstract][Full Text] [Related]
19. Ivabradine improves quality of life in subjects with chronic heart failure compared to treatment with β-blockers: results of a multicentric observational APULIA study.
Riccioni G; Masciocco L; Benvenuto A; Saracino P; De Viti D; Massari F; Meliota G; Buta F; Speziale G
Pharmacology; 2013; 92(5-6):276-80. PubMed ID: 24296869
[TBL] [Abstract][Full Text] [Related]
20. Early NT-proBNP decrease with ivabradine in ambulatory patients with systolic heart failure.
Sargento L; Satendra M; Longo S; Lousada N; Palma dos Reis R
Clin Cardiol; 2013 Nov; 36(11):677-82. PubMed ID: 23929789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]